Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide in VCIND
NCT02993367Phase 3Unknown
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butylphthalide in vascular cognitive impairment no dementia (VCIND), sponsored by The Second Hospital of Hebei Medical University. Status: unknown.
02
Drugs
butylphthalide
03
Conditions
vascular cognitive impairment no dementia (VCIND)
Beyond the preview
Go deeper on NCT02993367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02993367.